O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+10.04%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$8.27B
AUM Growth
+$8.27B
(-0.65%)
Cap. Flow
-$508M
Cap. Flow
% of AUM
-6.15%
Top 10 Holdings %
Top 10 Hldgs %
34.32%
Holding
163
New
21
Increased
24
Reduced
50
Closed
15
Top Buys
| 1 |
Humana
HUM
|
$108M |
| 2 |
Cigna
CI
|
$87.3M |
| 3 |
PRNB
Principia Biopharma Inc. Common Stock
PRNB
|
$76.1M |
| 4 |
Molina Healthcare
MOH
|
$72.7M |
| 5 |
Sarepta Therapeutics
SRPT
|
$64.9M |
Top Sells
| 1 |
Alnylam Pharmaceuticals
ALNY
|
$125M |
| 2 |
Biogen
BIIB
|
$91M |
| 3 |
Merck
MRK
|
$80.6M |
| 4 |
Select Medical
SEM
|
$74.3M |
| 5 |
Boston Scientific
BSX
|
$65.9M |
Sector Composition
| 1 | Healthcare | 95.17% |
| 2 | Financials | 0.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
UnitedHealth
UNH
$281B
| $49.6M | 0.6% | 186,500 +63,200 | +51% | +$16.8M |
|
52
Bausch Health
BHC
$2.74B
| $48.9M | 0.59% | +1,903,900 | New | +$48.9M |
|
53
Centene
CNC
$14.3B
| $48.8M | 0.59% | +337,400 | New | +$48.8M |
|
|
ONC
54
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $48.7M | 0.59% | 282,500 +21,100 | +8% | +$3.63M |
|
55
Heron Therapeutics
HRTX
$207M
| $47.9M | 0.58% | 1,514,500 +199,400 | +15% | +$6.31M |
|
|
OBSV
56
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $47M | 0.57% | 2,605,531 | – | – |
|
57
Assembly Biosciences
ASMB
$190M
| $45.8M | 0.55% | 1,233,371 +512,205 | +71% | +$19M |
|
58
eHealth
EHTH
$118M
| $45.5M | 0.55% | 1,611,200 -223,500 | -12% | -$6.32M |
|
59
Arvinas
ARVN
$568M
| $44.6M | 0.54% | +2,645,865 | New | +$44.6M |
|
60
Galapagos
GLPG
$2.07B
| $44M | 0.53% | 391,631 -95,359 | -20% | -$10.7M |
|
61
Teleflex
TFX
$5.59B
| $41.9M | 0.5% | 157,300 -33,100 | -17% | -$8.81M |
|
62
ProQR Therapeutics
PRQR
$237M
| $39.4M | 0.48% | 2,037,875 +734,920 | +56% | +$14.2M |
|
|
SPPI
63
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $38.1M | 0.46% | +2,265,500 | New | +$38.1M |
|
64
Insmed
INSM
$28.8B
| $37M | 0.45% | 1,829,300 -1,098,591 | -38% | -$22.2M |
|
65
Xtant Medical Holdings
XTNT
$83.3M
| $35.4M | 0.43% | 9,207,012 | – | – |
|
66
Zai Lab
ZLAB
$3.68B
| $34.2M | 0.41% | 1,753,538 +142,538 | +9% | +$2.78M |
|
67
KALA BIO
KALA
$78.8M
| $34M | 0.41% | 3,447,840 | – | – |
|
68
Amgen
AMGN
$155B
| $31.4M | 0.38% | 151,600 +27,500 | +22% | +$5.7M |
|
69
Tandem Diabetes Care
TNDM
$845M
| $30.6M | 0.37% | 714,500 -974,500 | -58% | -$41.7M |
|
|
INSY
70
DELISTED
Insys Therapeutics, Inc.
INSY
| $30.5M | 0.37% | 3,028,354 -483,190 | -14% | -$4.87M |
|
71
Rhythm Pharmaceuticals
RYTM
$6.85B
| $30.4M | 0.37% | 1,041,353 -1,023,647 | -50% | -$29.9M |
|
|
FOMX
72
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $29.8M | 0.36% | 5,195,330 +1,155,330 | +29% | +$6.62M |
|
73
Pfizer
PFE
$141B
| $29.5M | 0.36% | 668,700 -313,300 | -32% | -$13.8M |
|
74
Abbott
ABT
$231B
| $28.9M | 0.35% | 394,100 | – | – |
|
75
Synlogic
SYBX
$17M
| $28.8M | 0.35% | 2,029,996 | – | – |
|